Focus group parental opinions regarding treatment with topical corticosteroids on children with atopic dermatitis
Main Article Content
Keywords
Atopic dermatitis, Adrenal cortex hormones, Fears, Focus group
Abstract
Introduction and objectives: Atopic dermatitis is common among children of 0-5 years old. Treatment consists of emollients and topical corticosteroids. Due to corticophobia, however, adherence to topical corticosteroids is low. Our aim was to find factors that influence opinions about topical corticosteroids among parents of children with atopic dermatitis.
Methods: A qualitative focus group study in secondary care with parents of children with atopic dermatitis. Questions concerned opinions, attitude, sources of information, and the use of topical corticosteroids.
Results: The parents indicated that they lack knowledge about the working mechanism and side effects of topical corticosteroids. Dermatologists and paediatricians emphasise the beneficial effects, whereas other healthcare workers and lay people often express a negative attitude.
Conclusions: This study gives a complete overview of factors influencing adherence. Treatment with topical corticosteroids can be improved by better-informing parents about the working mechanisms, the use, and how to reduce the dose. Healthcare professionals need to be aware of the consequences of their negative attitude concerning topical corticosteroids.
References
2. Abramovits W. Atopic dermatitis. J Am Acad Dermatol. 2005;53:S86-93.
3. Weisshaar E, Diepgen TL, Bruckner T, Fartasch M, Kupfer J, LobCorzilius T, et al. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children. Acta Derm Venereol. 2008;88:234-9.
4. Nankervis H, Thomas KS, Delamere MF, Barbarot S, Smith S, Rogers NK, et al. What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials. Br J Dermatol. 2016;175:910-27.
5. Dirven-Meijer PC, De Kock CA, Nonneman MMG, Van Sleeuwen D, De Witt-de Jong AWF, Burgers JS, et al. NHG-Standaard Eczeem. Huisarts Wet. 2014;57:240-52.
6. Mueller SM, Itin P, Vogt DR, Walter M, Lang U, Griffin LL. Assessment of ‘‘corticophobia’’ as an indicator of non-adherence to topical corticosteroids: a pilot study. J Dermatol Treat. 2017;28:104-11.
7. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142:931-6.
8. Aubert-Wastiaux H, Moret L, Le Rhun A, Fontenoy AM, Nguyen JM, Leux C, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165:808-14.
9. Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56:211-6.
10. Müller SM, Tomaschett D, Euler S, Vogt DR, Herzog L, Itin P. Topical corticosteroid concerns in dermatological outpatients: a cross-sectional and interventional study. Dermatology. 2016;232:444-52.
11. Lee JY, Her Y, Kim CW, Kim SS. Topical corticosteroid phobia among parents of children with atopic eczema in Korea. Ann Dermatol. 2015;27:499-506.
12. Smith SD, Hong E, Fearns S, Blaszczynski A, Fischer G. Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Aust J Dermatol. 2010;51:168-74.
13. Smith SD, Farrugia LL, Harris V, Lee A, Carter SR, Blaszczynski A, et al. Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use. J Dermatol Treat. 2017;28: 642-6.
14. Farrugia LL, Lee A, Fischer G, Blaszczynski A, Carter SR, Smith SD. Evaluation of the influence of pharmacists and GPs on patient perceptions of long-term topical corticosteroid use. J Dermatol Treat. 2017;28: 112-8.
15. Smith SD, Harris V, Lee A, Blaszczynski A, Fischer G. General practitioners knowledge about use of topical corticosteroids in paediatric atopic dermatitis in Australia. Aust Fam Physician. 2017;46: 335-40.
16. Munidasa D, Lloyd-Lavery A, Burge S, McPherson T. What should general practice trainees learn about atopic eczema? J Clin Med. 2015;4:360-8.
17. Pustiˇsek N, ˇSitum M, Vurnek Zivkovi ˇ ´c M, Ljubojevi´c Hadˇzavdi´c S, Vurnek M, Niseteo T. The significance of structured parental educational intervention on childhood atopic dermatitis: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2016;30: 806-12.
18. Heratizadeh A, Werfel T, Wollenberg A, Abraham S, PlankHabibi S, Schnopp C. Effects of structured patient education in adults with atopic dermatitis: multicenter randomized controlled trial. J Allergy Clin Immunol. 2017;24: 845-53.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.